ABCA1/ApoA1 (Gilead Palo Alto)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameABCA1/ApoA1 (Gilead Palo Alto)
Drug Alias NameABCA1/ApoA1 (CV Therapeutics)dual action ATP binding cassette transporter 1 and apolipoprotein A1 modulators (CV Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein A-I modulatorsATP binding cassette subfamily A member 1 modulators
TargetsATP binding cassette subfamily A member 1Apolipoprotein A-I
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Palo Alto Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Palo Alto Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A